UnknownPhase 2

The Research of Standard Diagnosis and Treatment for Severe HSP in Children

China30 participantsStarted 2015-08

Plain-language summary

This study is performed to evaluate the efficacy and safety of various measures in the treatment of severe HSP in children.

Who can participate

Age range2 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Severe HSP: could not be controlled with dexamethasone 0.5mg/kg/d or the total dose above 20mg/d for more than two days Exclusion Criteria: * The children with congenital diseases

What they're measuring

The Symptoms of Digestive Tract

Timeframe: 2 weeks

The Symptoms of Joint System

Timeframe: 2 weeks

Trial details

NCT IDNCT02540720

SponsorNanjing Children's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-07

Contact for this trial

Aihua Zhang, M.D.

+8618951769017 bszah@163.com

View on ClinicalTrials.gov More Henoch-Schoenlein Purpura trials